摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-cyano-ethyl)-1H-pyrazole-3-carboxylic acid methyl ester | 1338812-46-6

中文名称
——
中文别名
——
英文名称
1-(2-cyano-ethyl)-1H-pyrazole-3-carboxylic acid methyl ester
英文别名
——
1-(2-cyano-ethyl)-1H-pyrazole-3-carboxylic acid methyl ester化学式
CAS
1338812-46-6
化学式
C8H9N3O2
mdl
——
分子量
179.178
InChiKey
WMZPDGIYYZNICB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.58
  • 重原子数:
    13.0
  • 可旋转键数:
    3.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    67.91
  • 氢给体数:
    0.0
  • 氢受体数:
    5.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(2-cyano-ethyl)-1H-pyrazole-3-carboxylic acid methyl esterlithium hydroxide monohydrate 作用下, 以 甲醇 为溶剂, 反应 26.0h, 以67%的产率得到1-(2-cyano-ethyl)-1H-pyrazole-3-carboxylic acid
    参考文献:
    名称:
    Discovery of Aryloxy Tetramethylcyclobutanes as Novel Androgen Receptor Antagonists
    摘要:
    An aryloxy tetramethylcyclobutane was identified as a novel template for androgen receptor (AR) antagonists via cell-based high-throughput screening. Follow-up to the initial "hit" established 5 as a viable lead. Further optimization to achieve full AR antagonism led to the discovery of 26 and 30, both of which demonstrated excellent in vivo tumor growth inhibition upon oral administration in a castration-resistant prostate cancer (CRPC) animal model.
    DOI:
    10.1021/jm201059s
  • 作为产物:
    描述:
    吡唑-3-羧酸甲酯丙烯腈1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下, 以 乙腈 为溶剂, 反应 26.0h, 以96%的产率得到1-(2-cyano-ethyl)-1H-pyrazole-3-carboxylic acid methyl ester
    参考文献:
    名称:
    Discovery of Aryloxy Tetramethylcyclobutanes as Novel Androgen Receptor Antagonists
    摘要:
    An aryloxy tetramethylcyclobutane was identified as a novel template for androgen receptor (AR) antagonists via cell-based high-throughput screening. Follow-up to the initial "hit" established 5 as a viable lead. Further optimization to achieve full AR antagonism led to the discovery of 26 and 30, both of which demonstrated excellent in vivo tumor growth inhibition upon oral administration in a castration-resistant prostate cancer (CRPC) animal model.
    DOI:
    10.1021/jm201059s
点击查看最新优质反应信息